Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/LentiGlobin_BB305> ?p ?o }
Showing triples 1 to 36 of
36
with 100 triples per page.
- LentiGlobin_BB305 abstract "LentiGlobin BB305 is an experimental treatment for beta thalassemia, a rare and potentially debilitating blood disorder. It is being developed by Bluebird Bio and was given “breakthrough therapy” designation by the Food and Drug Administration in February, 2015. In early clinical trials several patients with beta thalassemia, who usually require frequent blood transfusions to treat their disease, were able to forgo blood transfusions for extended periods of time.".
- LentiGlobin_BB305 wikiPageExternalLink rare-diseases.
- LentiGlobin_BB305 wikiPageID "45389775".
- LentiGlobin_BB305 wikiPageLength "3864".
- LentiGlobin_BB305 wikiPageOutDegree "16".
- LentiGlobin_BB305 wikiPageRevisionID "696181064".
- LentiGlobin_BB305 wikiPageWikiLink Anemia.
- LentiGlobin_BB305 wikiPageWikiLink Beta_thalassemia.
- LentiGlobin_BB305 wikiPageWikiLink Bluebird_Bio.
- LentiGlobin_BB305 wikiPageWikiLink Category:Biotechnology.
- LentiGlobin_BB305 wikiPageWikiLink Category:Disorders_of_globin_and_globulin_proteins.
- LentiGlobin_BB305 wikiPageWikiLink Category:Gene_delivery.
- LentiGlobin_BB305 wikiPageWikiLink Category:Hereditary_hemolytic_anemias.
- LentiGlobin_BB305 wikiPageWikiLink Category:Medical_genetics.
- LentiGlobin_BB305 wikiPageWikiLink Ex_vivo.
- LentiGlobin_BB305 wikiPageWikiLink Food_and_Drug_Administration.
- LentiGlobin_BB305 wikiPageWikiLink Gene_therapy.
- LentiGlobin_BB305 wikiPageWikiLink HBB.
- LentiGlobin_BB305 wikiPageWikiLink Hematopoietic_stem_cell.
- LentiGlobin_BB305 wikiPageWikiLink Hemoglobin.
- LentiGlobin_BB305 wikiPageWikiLink Viral_vector.
- LentiGlobin_BB305 wikiPageWikiLinkText "LentiGlobin BB305".
- LentiGlobin_BB305 wikiPageUsesTemplate Template:Medicine.
- LentiGlobin_BB305 wikiPageUsesTemplate Template:Reflist.
- LentiGlobin_BB305 subject Category:Biotechnology.
- LentiGlobin_BB305 subject Category:Disorders_of_globin_and_globulin_proteins.
- LentiGlobin_BB305 subject Category:Gene_delivery.
- LentiGlobin_BB305 subject Category:Hereditary_hemolytic_anemias.
- LentiGlobin_BB305 subject Category:Medical_genetics.
- LentiGlobin_BB305 hypernym Treatment.
- LentiGlobin_BB305 type Drug.
- LentiGlobin_BB305 comment "LentiGlobin BB305 is an experimental treatment for beta thalassemia, a rare and potentially debilitating blood disorder. It is being developed by Bluebird Bio and was given “breakthrough therapy” designation by the Food and Drug Administration in February, 2015. In early clinical trials several patients with beta thalassemia, who usually require frequent blood transfusions to treat their disease, were able to forgo blood transfusions for extended periods of time.".
- LentiGlobin_BB305 label "LentiGlobin BB305".
- LentiGlobin_BB305 sameAs m.012vp9g7.
- LentiGlobin_BB305 wasDerivedFrom LentiGlobin_BB305?oldid=696181064.
- LentiGlobin_BB305 isPrimaryTopicOf LentiGlobin_BB305.